Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › pimecrolimus

pimecrolimus

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of pimecrolimus

3 trials tracked of pimecrolimus: 2 in phase 3 or 4.

3Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 1 Other / NA 1
  1. Phase 4 Combination Therapy for Atopic Dermatitis Completed
  2. Phase 3 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis Completed
  3. N/A Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With Eczema Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Dupilumab for Severe Pediatric Atopic Dermatitis Followed by Vitiligo Three Months Later
Oncology Sys. Review
Dupilumab for Severe Pediatric Atopic Dermatitis Followed by Vitiligo Three Months Later Child Develops Vitiligo After Starting Dupilumab
This is a case report and literature review describing an 8-year-11-month-old girl with severe atopic dermatitis who developed vitiligo thre…
A young girl with severe eczema developed vitiligo three months after starting dupilumab, but a link is not proven.
Frontiers Sep 30, 2026
Network meta-analysis of pediatric atopic dermatitis treatments shows dupilumab and pimecrolimus efficacy
Neurology Meta-analysis
Network meta-analysis of pediatric atopic dermatitis treatments shows dupilumab and pimecrolimus efficacy Dupilumab and Pimecrolimus Lead New Rankings for Children's Eczema Relief
This network meta-analysis evaluated dupilumab, pimecrolimus, melatonin, probiotics, tralokinumab, nemolizumab, and vitamin D for pediatric …
A new analysis ranks the top treatments for children's eczema, with dupilumab and pimecrolimus leading for symptom relief.
Frontiers May 2, 2026